<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The raised score in the revised Hasegawa <z:hpo ids='HP_0000726'>dementia</z:hpo> scales (HDS) demonstrated that the effect of Yi Zhi Capsules (YZC) in treating loss of intellectual function after cerebrovascular diseases was significantly better than that of the western drug Piracetam [symbol: see text] (P &lt; 0.01) </plain></SENT>
<SENT sid="1" pm="."><plain>The morbidity of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> was much lower in the treatment group than that of the control group (P &lt; 0.05) after a one-year follow-up; and the blood <z:chebi fb="23" ids="18059">lipid</z:chebi> level and some indexes in rheological examinations were also improved significantly (P &lt; 0.05, or &lt; 0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>The data indicate that YZC is a relatively good preparation for prevention of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>